Gayatri Herbals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-07-2024
- Paid Up Capital ₹ 0.90 M
as on 17-07-2024
- Company Age 28 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -7.88%
(FY 2023)
- Profit -44.75%
(FY 2023)
- Ebitda 18.09%
(FY 2023)
- Net Worth -7.52%
(FY 2023)
- Total Assets 40.58%
(FY 2023)
About Gayatri Herbals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Ulhas Karle, Amalesh Karle, and Sangeeta Karle serve as directors at the Company.
- CIN/LLPIN
U24239MH1996PTC095967
- Company No.
095967
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Gayatri Herbals Private Limited offer?
Gayatri Herbals Private Limited offers a wide range of products and services, including Fertilizers and Soil Additives, Organic Fertilizers and Manure, Cosmetics, Hair & Beauty Products, Eye Cosmetic, Pet Furniture & Products, Pet Grooming Tools, Cold Cream, Ayurvedic, Herbal Oils and Cosmetics, Aloe Vera Cream, Herbal Skin Care Cosmetics.
Who are the key members and board of directors at Gayatri Herbals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amalesh Karle  | Managing Director | 01-Apr-2010 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ulhas Karle | Director | 05-Jan-1996 | Current |
| Sangeeta Karle | Director | 03-Feb-2021 | Current |
Financial Performance and Corporate Structure Insights of Gayatri Herbals.
Gayatri Herbals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.88% decrease. The company also saw a substantial fall in profitability, with a 44.75% decrease in profit. The company's net worth dipped by a decrease of 7.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gayatri Herbals?
In 2023, Gayatri Herbals had a promoter holding of 97.78% and a public holding of 2.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gayatri Herbals?
Unlock and access historical data on people associated with Gayatri Herbals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gayatri Herbals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gayatri Herbals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
